Premium
The effects of short‐term oral phytoestrogen supplementation on the hypothalamic‐pituitary‐testicular axis in prostate cancer patients
Author(s) -
Rannikko Antti,
Petas Anssi,
Raivio Taneli,
Jänne Olli A.,
Rannikko Sakari,
Adlercreutz Herman
Publication year - 2006
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.20437
Subject(s) - medicine , prostate cancer , hypothalamic–pituitary–gonadal axis , prostate , cancer , endocrinology , oncology , gynecology , urology , hormone , luteinizing hormone
Background Here we evaluate the effects of oral phytoestrogen supplementation on hypothalamic‐pituitary‐testicular (HPT) axis in CaP patients. Methods We recruited 40 men about to undergo radical prostatectomy for CaP to receive either 240 mg of clover phytoestrogens or placebo daily for 2 weeks. Serum hormone levels were measured before and after treatment. In addition, recombinant cell bioassay was used to measure serum androgen bioactivity (ABA). Results Phytoestrogen treatment increased serum LH from mean of 3.4–5.2 IU, P = 0.03. Concomitantly, non‐significant trend towards decline in serum T, cfT and ABA values was noted. However, mean serum LH/T ratio was upregulated from 0.20 to 0.48 IU/nM, P = 0.004, suggesting compensated hypogonadism. During the course of treatment, serum concentration of equol correlated strongly with the concomitant decrease in ABA (r = −0.586, P = 0.022). Conclusions Phytoestrogen treatment interferes with HPT axis in CaP patients by inducing testicular resistance to LH and compensated hypogonadism. Prostate 66: 1086‐1091, 2006. © 2006 Wiley‐Liss, Inc.